| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $35,768,675 ) (Continued on the next page) |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R61AI169026 | Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis | 000 | 2 | NIH | 4/28/2023 | $263,088 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI170197 | Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS | 000 | 2 | NIH | 1/18/2023 | $989,774 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P30AI168439 | Interdisciplinary NexGen TB research Advancement Center (IN-TRAC) | 000 | 2 | NIH | 2/2/2023 | $1,150,146 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI166049 | Genomic consequences of schistosome hybridization | 000 | 3 | NIH | 8/23/2023 | $628,539 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD036038 | Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource | 000 | 1 | NIH | 9/8/2023 | $4,000,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD031898 | Characterizing IL-22 driven chronic immune activation in HIV/TB co-pandemic | 000 | 3 | NIH | 1/14/2023 | $188,995 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 002 | 22 | NIH | 7/27/2023 | $1,558,771 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD036038 | Further expansion of the Southwest National Primate Research Center Specific Pathogen Free Rhesus Macaque Resource | 000 | 1 | NIH | 9/8/2023 | $4,000,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21NS135258 | Modeling chikungunya virus neuroinvasion and neuropathogenesis in mice | 000 | 1 | NIH | 9/6/2023 | $544,500 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01DA052845 | Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection | 000 | 4 | NIH | 7/7/2023 | $696,885 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R03AI174973 | Determining the Functional Significance of Mutations Observed in Envelope Protein Following Serial In Vivo Passaging of Human-Simian Immunodeficiency Virus | 000 | 1 | NIH | 8/1/2023 | $99,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AG065546 | Microbiome-mediated therapies for aging and healthspan in marmosets | 000 | 4 | NIH | 6/8/2023 | $604,840 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 003 | 22 | NIH | 8/8/2023 | $0 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 000 | 22 | NIH | 2/24/2023 | $2,417,980 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 002 | 5 | NIH | 3/11/2023 | $72,915 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 005 | 25 | NIH | 7/6/2023 | $490,176 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 001 | 25 | NIH | 4/20/2023 | $7,483,557 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 003 | 25 | NIH | 5/2/2023 | $499,999 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 002 | 25 | NIH | 5/1/2023 | $73,260 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | F99AG079802 | Elucidate the adverse impact of mitochondria-induced oxidative stress in molecular and cellular determinants in the aging lung, driving susceptibility to Mycobacterium tuberculosis infection | 000 | 2 | NIH | 8/14/2023 | $36,974 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI168934 | Novel antiviral strategy offering forward capability and reduced risk of escape | 000 | 1 | NIH | 4/4/2023 | $297,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01HL145411 | Predicting tuberculosis outcomes using genotypic and biomarker signatures | 001 | 5 | NIH | 1/14/2023 | $729,753 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 004 | 25 | NIH | 5/31/2023 | $1,943,312 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 000 | 21 | NIH | 11/7/2022 | $970,185 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R56AI174877 | Donor-specific anti-HIV/SIV immunity mediated by APOBEC3 enzymes | 000 | 1 | NIH | 4/1/2023 | $833,457 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI176309 | Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas | 000 | 1 | NIH | 4/5/2023 | $956,440 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 2 | NIH | 2/8/2023 | $391,538 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI134245 | Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma | 002 | 7 | NIH | 4/14/2023 | $1,130,921 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01MH130193 | Brain myeloid cell-targeted multiplexed gene editing for SIV/HIV eradication | 000 | 2 | NIH | 2/8/2023 | $403,691 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI170148 | Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection | 000 | 2 | NIH | 7/14/2023 | $387,333 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI165289 | Pigtail Macaque Model of Human-Simian Immunodeficiency Virus Infection | 000 | 2 | NIH | 7/7/2023 | $378,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI172539 | Durable HIV Vaccine Targeting Mucosal Epithelium | 000 | 2 | NIH | 7/20/2023 | $939,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R25GM142021 | It's Contagious! Promoting the Biomedical Workforce Pipeline through Infectious Diseases | 000 | 2 | NIH | 5/22/2023 | $261,438 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R61AI169026 | Advancing Innovative Next_generation Heterologous Vaccines Against Tuberculosis | 000 | 2 | NIH | 4/28/2023 | $263,089 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI171601 | Role of the microbiome of the schistosome snail host | 000 | 2 | NIH | 4/6/2023 | $297,000 |
| 2023 | 2023 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI157850 | Role of cellular long non-coding RNAs in HIV replication and disease outcome | 000 | 2 | NIH | 7/12/2023 | $495,000 |
| 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | U42OD010442 | Establishment of a SPF Rhesus Macaque Colony | 001 | 21 | NIH | 7/27/2023 | -$1,558,771 |
| 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD026529 | Pathogenesis of and host response to chikungunya virus infection of the central nervous system | 003 | 6 | NIH | 6/15/2023 | $917 |
| 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | P51OD011133 | The Southwest National Primate Research Center- Marmoset Housing Supplement 2023 | 000 | 24 | NIH | 11/8/2022 | $0 |
| 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | K01OD026529 | Pathogenesis of and host response to chikungunya virus infection of the central nervous system | 001 | 6 | NIH | 2/15/2023 | $118,541 |
| 2023 | 2022 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI134240 | Immune Correlates of Protection from TB | 000 | 5 | NIH | 5/9/2023 | $0 |
| 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD030079 | Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS research | 000 | 1 | NIH | 11/2/2022 | $0 |
| 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R37AI048071 | Mapping Drug Resistance Genes in Plasmodium falciparum | 000 | 20 | NIH | 11/7/2022 | $0 |
| 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI152200 | Engineering pathogen triggered biomineralization to enable a new generation of point-of-care tests | 000 | 2 | NIH | 4/4/2023 | $0 |
| 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R21AI150445 | Determining the efficacy of a novel TB diagnostic test to monitor treatment success in drug resistant TB patients | 000 | 2 | NIH | 1/17/2023 | $0 |
| 2023 | 2021 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | C06OD030079 | Significant expansion of the SNPRC Specific Pathogen Free Rhesus Macaque Colony for AIDS research | 001 | 1 | NIH | 1/30/2023 | $0 |
| 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R56AI150371 | HIV- induced long non-coding RNAs in viral replication and immune response | 000 | 1 | NIH | 1/30/2023 | $0 |
| 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI123047 | Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement | 001 | 5 | NIH | 1/30/2023 | -$1,734 |
| 2023 | 2020 | TEXAS BIOMEDICAL RESEARCH INSTITUTE | 8715 W MILITARY DR | SAN ANTONIO | TX | 78227-5302 | BEXAR | USA | R01AI123047 | Impact of concurrent HIV and latent TB therapies on Mtb-specific immune function-Diversity Supplement | 000 | 5 | NIH | 1/30/2023 | -$10,454 |
|